18 min listen
Evaluation of Microhematuria: A Risk-based Approach - Frankly Speaking Ep 199
Evaluation of Microhematuria: A Risk-based Approach - Frankly Speaking Ep 199
ratings:
Length:
14 minutes
Released:
Nov 23, 2020
Format:
Podcast episode
Description
Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-199
Overview: Microhematuria is a common finding. It is usually benign, but it needs proper evaluation since it may also be a sign of malignancy. A risk-based approach can avoid unnecessary testing, while still identifying those patients with malignancy. Recent American Urological Association (AUA) guidelines use a validated risk-based approach.
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-199
Overview: Microhematuria is a common finding. It is usually benign, but it needs proper evaluation since it may also be a sign of malignancy. A risk-based approach can avoid unnecessary testing, while still identifying those patients with malignancy. Recent American Urological Association (AUA) guidelines use a validated risk-based approach.
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato
Released:
Nov 23, 2020
Format:
Podcast episode
Titles in the series (100)
Breast Cancer and the Harms of Overdiagnosis - Frankly Speaking EP6: In this podcast episode, we consider the premise of overdiagnosis and how it applies to women being screened for breast cancer and highlight ways to mitigate the risks of overdiagnosis of breast cancer. by Frankly Speaking About Family Medicine